A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany

BackgroundThis epidemiologic cohort study documented clinical and serological data in MS patients over several vaccination cycles against severe respiratory syndrome coronavirus-2 (SARS-CoV-2) in a real-world setting.MethodsAdult patients with MS were included during a period of 26 months from July...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Achim Berthele, Clemens Gödel, Boris-Alexander Kallmann, Markus Kowarik, Klaus Lehmann-Horn, Martin Marziniak, Sebastian Rauer, Veit Rothhammer, Florian Then Bergh, Mathias Wahl, Brigitte Wildemann, Ksenija Schirduan
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2025-10-01
סדרה:	Frontiers in Neurology
נושאים:	multiple sclerosis SARS-CoV-2 vaccination immune response disease-modifying therapy
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1674742/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!